Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine: A Phase 3 Randomized Clinical Trial.

Vesikari T, Finn A, van Damme P, Leroux-Roels I, Leroux-Roels G, Segall N, Toma A, Vallieres G, Aronson R, Reich D, Arora S, Ruane PJ, Cone CL, Manns M, Cosgrove C, Faust SN, Ramasamy MN, Machluf N, Spaans JN, Yassin-Rajkumar B, Anderson D, Popovic V, Diaz-Mitoma F, CONSTANT Study Group

Open source

DOI: 10.1001/jamanetworkopen.2021.28652
Published: 2021 Oct 1
Container: JAMA network open
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamanetworkopen.2021.28652,
  title = {Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine: A Phase 3 Randomized Clinical Trial.},
  author = {Vesikari T and Finn A and van Damme P and Leroux-Roels I and Leroux-Roels G and Segall N and Toma A and Vallieres G and Aronson R and Reich D and Arora S and Ruane PJ and Cone CL and Manns M and Cosgrove C and Faust SN and Ramasamy MN and Machluf N and Spaans JN and Yassin-Rajkumar B and Anderson D and Popovic V and Diaz-Mitoma F and CONSTANT Study Group},
  year = {2021},
  journal = {JAMA network open},
  doi = {10.1001/jamanetworkopen.2021.28652},
  url = {https://doi.org/10.1001/jamanetworkopen.2021.28652}
}

RIS

TY  - JOUR
TI  - Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine: A Phase 3 Randomized Clinical Trial.
AU  - Vesikari T
AU  - Finn A
AU  - van Damme P
AU  - Leroux-Roels I
AU  - Leroux-Roels G
AU  - Segall N
AU  - Toma A
AU  - Vallieres G
AU  - Aronson R
AU  - Reich D
AU  - Arora S
AU  - Ruane PJ
AU  - Cone CL
AU  - Manns M
AU  - Cosgrove C
AU  - Faust SN
AU  - Ramasamy MN
AU  - Machluf N
AU  - Spaans JN
AU  - Yassin-Rajkumar B
AU  - Anderson D
AU  - Popovic V
AU  - Diaz-Mitoma F
AU  - CONSTANT Study Group
PY  - 2021
JO  - JAMA network open
DO  - 10.1001/jamanetworkopen.2021.28652
UR  - https://doi.org/10.1001/jamanetworkopen.2021.28652
ER  -

APA

T, V., A, F., P, V. D., I, L., G, L., N, S., A, T., G, V., R, A., D, R., S, A., PJ, R., CL, C., M, M., C, C., SN, F., MN, R., N, M., JN, S., B, Y., D, A., V, P., F, D., & Group, C. S. (2021). Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine: A Phase 3 Randomized Clinical Trial.. JAMA network open. https://doi.org/10.1001/jamanetworkopen.2021.28652

Source records

pubmed · retrieved 2026-09-25T13:31:25.676Z